๐ฐ Phi Therapeutics News
Phi Therapeutics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Phi Therapeutics. Real-time updates on events, politics, business and more.
April 12, 2024
Shiseido is one of the top 100 cosmetic companies of 2023.
December 12, 2023
The Japanese beauty giant has announced the launch of Shiseido Long Term Investments for the Future (LIFT) Ventures, a newly formed limited liability company, which will be a vehicle for investing in innovative early-stage companies within the beauty wellness space. LIFT Ventures is focused on investing behind novel technologies, innovative platforms, high-growth brands, and new business models, among others. The fund will primarily focus on compelling innovation in the Western hemisphere,......
December 8, 2023
Japanese beauty giant Shiseido is looking to invest in early-stage companies in the beauty and wellness space with its new firm, LIFT Ventures.
December 13, 2022
DUBLIN--(BUSINESS WIRE)--The "BioGeNe Series 2023" conference has been added to ResearchAndMarkets.com's offering.The host is here with a platform for pharmaceutical, biotechnology professionals and technology providers to come together at the BioGeNe 2023 Confex on the 8th - 9th February 2023 in San Diego-USA to di...
July 13, 2022
/PRNewswire/ -- Phylas mission to make benzoyl peroxide obsolete for acne is off to a great start. Phylas acne serum tackles the root cause of acne without...
February 23, 2021
Phyla Announces Results Of Acne Clinical Trial Demonstrating The Power of Live Probiotic Phage Results Show Live Probiotic Naturally Found On Skin Reduces C. acnes Bacteria by 17% News provided by Share this article Share this article SAN FRANCISCO, Feb. 23, 2021 /PRNewswire/ --ย Phyla announced the release of results from a clinical study for its Phortify Probiotic Serum containing the brands flagship probiotic live phage. Phyla is a brand of Phi Therapeutics, Inc., a venture-backed microbiome...
February 22, 2021
4 Bacteriophages therapy marketย is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to reach at an estimated value of USD 140.76 million and grow at a CAGR of 16.76% in the above-mentioned forecast period. Increasing prevalence of drug-resistant infections drives the bacteriophages therapy market. Bacteriophages Therapy report provides the solid foundation required to accomplish the variety of business challenges that come...
February 8, 2021
This market study on Bacteriophages Therapy Market covers The market study conducted in this report analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, and distributors in the industry. Also, it sheds light on the wide-ranging competitive landscape of the global Bacteriophages Therapy market. It defines about the recent innovations, applications and end users of the market.The report first...